Home > Financial Ratios > GLENMARK LIFE SCIENCES

GLENMARK LIFE SCIENCES
Core EBITDA Growth

    Back to All Ratios
GLENMARK LIFE SCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLENMARK LIFE SCIENCES
Please provide your vote to see the results

GLENMARK LIFE SCIENCES Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 2.246.426.5722.3095.01

What is the latest Core EBITDA Growth ratio of GLENMARK LIFE SCIENCES ?

The latest Core EBITDA Growth ratio of GLENMARK LIFE SCIENCES is 2.24 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar20242.24
Mar20236.42
Mar20226.57
Mar202122.30
Mar202095.01

How is Core EBITDA Growth of GLENMARK LIFE SCIENCES Trending?

Years Core EBITDA Growth % Change
Mar2024 2.24
-65.11
Mar2023 6.42
-2.28
Mar2022 6.57
-70.54
Mar2021 22.3
-76.53
Mar2020 95.01 -

Other Financial Ratios of GLENMARK LIFE SCIENCES


Compare Core EBITDA Growth ratio of peers of GLENMARK LIFE SCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK LIFE SCIENCES ₹13,067.1 Cr -1.6% 2.6% 74.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,271.0 Cr -0.9% -4.8% 50.2% Stock Analytics
DIVIS LABORATORIES ₹161,183.0 Cr 3% 5.9% 65% Stock Analytics
CIPLA ₹120,605.0 Cr 1.5% 0.1% 19.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,869.0 Cr -0.4% -8.2% 7.1% Stock Analytics
ZYDUS LIFESCIENCES ₹95,808.6 Cr 0.6% -5.3% 51% Stock Analytics


GLENMARK LIFE SCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK LIFE SCIENCES

-1.6%

2.6%

74.8%

SENSEX

3.5%

-0.1%

21.9%


You may also like the below Video Courses